 | Up a level |
Stritt, Kevin; Fuster, Daniel G; Dhayat, Nasser A; Bonny, Olivier; Faller, Nicolas; Christe, Andreas; Taha, Anas; Ochs, Vincent; Ortlieb, Niklas; Roth, Beat (2024). Risk factors for asymptomatic kidney stone passage in adults with recurrent kidney stones. (In Press). Clinical journal of the American Society of Nephrology, 19(9), pp. 1130-1137. Lippincott, Williams & Wilkins 10.2215/CJN.0000000000000496
Bargagli, Matteo; Vetsch, Andri; Anderegg, Manuel A; Dhayat, Nasser A; Huynh-Do, Uyen; Faller, Nicolas; Vogt, Bruno; Ferraro, Pietro Manuel; Fuster, Daniel G (2023). Tolvaptan treatment is associated with altered mineral metabolism parameters and increased bone mineral density in ADPKD patients. Nephrology, dialysis, transplantation, 38(7), pp. 1645-1654. Oxford University Press 10.1093/ndt/gfac298
Ferraro, Pietro Manuel; Bargagli, Matteo; Faller, Nicolas; Anderegg, Manuel A; Huynh-Do, Uyen; Vogt, Bruno; Gambaro, Giovanni; Fuster, Daniel G (2023). The role of urinary supersaturations for lithogenic salts in the progression of autosomal dominant polycystic kidney disease. Journal of nephrology JN, 36(4), pp. 1011-1018. Wichtig Editore 10.1007/s40620-022-01540-5
Dhayat, Nasser A; Bonny, Olivier; Roth, Beat; Christe, Andreas; Ritter, Alexander; Mohebbi, Nilufar; Faller, Nicolas; Pellegrini, Lisa; Bedino, Giulia; Venzin, Reto M; Grosse, Philipp; Hüsler, Carina; Koneth, Irene; Bucher, Christian; Del Giorno, Rosaria; Gabutti, Luca; Mayr, Michael; Odermatt, Urs; Buchkremer, Florian; Ernandez, Thomas; ... (2023). Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence. New England journal of medicine NEJM, 388(9), pp. 781-791. Massachusetts Medical Society MMS 10.1056/NEJMoa2209275
Schietzel, Simeon; Bally, Lia; Cereghetti, Grazia; Faller, Nicolas; Moor, Matthias B; Vogt, Bruno; Rintelen, Felix; Trelle, S; Fuster, Daniel (2022). Impact of the SGLT2 inhibitor empagliflozin on urinary supersaturations in kidney stone formers (SWEETSTONE trial): protocol for a randomised, double-blind, placebo-controlled cross-over trial. BMJ open, 12(3), e059073. BMJ Publishing Group 10.1136/bmjopen-2021-059073
Faller, Nicolas; Dhayat, Nasser; Fuster, Daniel Guido (2019). Nephrolithiasis secondary to inherited defects in the thick ascending loop of henle and connecting tubules. Urolithiasis, 47(1), pp. 43-56. Springer 10.1007/s00240-018-1097-z
Dhayat, Nasser; Faller, Nicolas; Rintelen, Felix; Roumet, Marie Camille; Irincheeva, Irina; Trelle, Sven; Tamò, Luca; Roth, Beat; Vogt, Bruno; Fuster, Daniel G (2018). Efficacy of standard and low dose hydrochlorothiazide in the recurrence prevention of calcium nephrolithiasis (NOSTONE trial): protocol for a randomized double-blind placebo-controlled trial. BMC nephrology, 19(1), p. 349. BioMed Central 10.1186/s12882-018-1144-6
Faller, Nicolas; Limacher, Andreas; Méan, Marie; Righini, Marc; Aschwanden, Markus; Beer, Jürg Hans; Frauchiger, Beat; Osterwalder, Josef; Kucher, Nils; Lämmle, Bernhard; Cornuz, Jacques; Angelillo-Scherrer, Anne; Matter, Christian M.; Husmann, Marc; Banyai, Martin; Staub, Daniel; Mazzolai, Lucia; Hugli, Olivier; Rodondi, Nicolas and Aujesky, Drahomir (2017). Predictors and Causes of Long-Term Mortality in Elderly Patients with Acute Venous Thromboembolism: A Prospective Cohort Study. American journal of medicine, 130(2), pp. 198-206. Elsevier 10.1016/j.amjmed.2016.09.008
Hofmann, Eveline; Faller, Nicolas; Limacher, Andreas; Méan, Marie; Tritschler, Tobias; Rodondi, Nicolas; Aujesky, Drahomir (2016). Educational Level, Anticoagulation Quality, and Clinical Outcomes in Elderly Patients with Acute Venous Thromboembolism: A Prospective Cohort Study. PLoS ONE, 11(9), e0162108. Public Library of Science 10.1371/journal.pone.0162108
Hofmann, Eveline; Faller, Nicolas; Limacher, Andreas; Méan, Marie; Tritschler, Tobias; Aujesky, Drahomir (2016). Educational Level, Anticoagulation Quality, and Clinical Outcomes in Elderly Patients with Acute Venous Thromboembolism: a Prospective Cohort Study [Dataset]. In: Educational Level, Anticoagulation Quality, and Clinical Outcomes in Elderly Patients with Acute Venous Thromboembolism.
